number of ozempic wegovy prescriptions q3 2024 semaglutide tirzepatide shortage ends as FDA sets deadline for compounders Wegovy vs. Ozempic: What To

To date, the latter includes the GLP-1 RAs liraglutide and semaglutide, and the SGLT2 inhibitors empagliflozin and canagliflozin

Therefore, patients with a history of gastrointestinal disorders are advised to use GLP-1RAs with caution in order to avoid poor tolerance and compliance

For the subset of semaglutide users who experience diarrhea rather than constipation, especially during the first week on semaglutide or after dose increases, S

In the SURMOUNT-1 trial, participants without diabetes lost an average of 15-22% of their body weight over 72 weeks, depending on the dose (5-15mg)

It targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, providing a stronger effect on hunger and metabolism

Lalezar and team!!!